|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,779 JPY | +1.86% |
|
+1.61% | -12.34% |
| Apr. 11 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
| Jan. 12 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
Hisamitsu Pharmaceutical Co., Inc. reported earnings results for the half year ended August 31, 2023. For the half year, the company reported sales was JPY 66,977 million compared to JPY 59,619 million a year ago. Net income was JPY 8,417 million compared to JPY 6,504 million a year ago.
Basic earnings per share from continuing operations was JPY 108.34 compared to JPY 81.58 a year ago. Diluted earnings per share from continuing operations was JPY 108.23 compared to JPY 81.51 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.34% | 1.82B | |
| +25.83% | 661B | |
| +26.62% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.79% | 231B | |
| +5.37% | 200B | |
| -8.88% | 195B | |
| -6.26% | 145B |
HISAMITSU PHARMACEUTICAL CO., INC. 
